Insights

Expanding Distribution Channels Adapt Pharma has developed dedicated online platforms like NARCANDirect.com to streamline sales and distribution, indicating a strategic focus on expanding access points for group purchasers such as hospitals, law enforcement, and community organizations, which presents opportunities to upsell or offer bundled solutions.

Strong Market Focus The company's recent marketing efforts, including TV advertising in key cities, demonstrate an acute focus on increasing awareness and adoption of Naloxone products among pharmacies and first responders, creating potential sales avenues through targeted outreach to healthcare providers and emergency services.

Strategic Acquisition and Growth Since its acquisition by Emergent BioSolutions in 2018, Adapt Pharma has benefited from increased production capabilities and access to broader distribution channels, presenting opportunities to facilitate larger volume sales and enter new institutional markets such as educational and correctional facilities.

Sustainability and Impact Adapt Pharma's mission centered around accessible and reliable overdose reversal treatments aligns with growing public health initiatives, opening avenues to partner with governmental agencies, NGOs, and healthcare systems focused on community-based opioid overdose prevention.

Innovative Digital Engagement With a digital presence supported by platforms like Google Analytics and targeted content, there are opportunities to leverage data-driven marketing strategies, improve engagement with potential healthcare partners, and identify emerging markets for Naloxone distribution and education campaigns.

Adapt Pharma Tech Stack

Adapt Pharma uses 7 technology products and services including CIM Technologies, WordPress, Twemoji, and more. Explore Adapt Pharma's tech stack below.

  • CIM Technologies
    Cad & Graphics
  • WordPress
    Content Management System
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts

Media & News

Adapt Pharma's Email Address Formats

Adapt Pharma uses at least 1 format(s):
Adapt Pharma Email FormatsExamplePercentage
First.Last@adaptpharma.comJohn.Doe@adaptpharma.com
46%
LastF@adaptpharma.comDoeJ@adaptpharma.com
6%
FirstL@adaptpharma.comJohnD@adaptpharma.com
2%
First.Last@adaptpharma.comJohn.Doe@adaptpharma.com
46%

Frequently Asked Questions

What is Adapt Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Adapt Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adapt Pharma's official website and social media links?

Minus sign iconPlus sign icon
Adapt Pharma's official website is adaptpharma.com and has social profiles on LinkedIn.

What is Adapt Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Adapt Pharma's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Adapt Pharma have currently?

Minus sign iconPlus sign icon
As of December 2025, Adapt Pharma has approximately 25 employees across 2 continents, including North AmericaEurope. Key team members include Associate Director Of Community Health Solutions: M. F.Associate Director Of Community Health Solutions: A. M.Associate Director Of Community Health Solutions: J. G.. Explore Adapt Pharma's employee directory with LeadIQ.

What industry does Adapt Pharma belong to?

Minus sign iconPlus sign icon
Adapt Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Adapt Pharma use?

Minus sign iconPlus sign icon
Adapt Pharma's tech stack includes CIM TechnologiesWordPressTwemojijQueryPHPGoogle AnalyticsAdobe Fonts.

What is Adapt Pharma's email format?

Minus sign iconPlus sign icon
Adapt Pharma's email format typically follows the pattern of First.Last@adaptpharma.com. Find more Adapt Pharma email formats with LeadIQ.

When was Adapt Pharma founded?

Minus sign iconPlus sign icon
Adapt Pharma was founded in 2014.

Adapt Pharma

Pharmaceutical ManufacturingLeinster, Ireland11-50 Employees

Adapt Pharma is an innovative small business focused on developing cutting-edge treatments for patients with special medical conditions. Our mission is to provide simple, reliable, and accessible therapeutic options, ensuring that patients, and those who care for them, have access to the right treatment at the right time.
 
On November 18, 2015, after Fast Track Designation and Priority Review, the US Food and Drug Administration (FDA) approved NARCAN® (naloxone HCl) Nasal Spray 4mg for commercial use in the United States. NARCAN® Nasal Spray became commercially available in early 2016.
 
Visit www.NarcanNasalSpray.com to learn more. Find the official press release, including Indications and Important Safety Information at http://adaptpharma.com/news-events/press-releases/
 
Group purchasers, such as law enforcement, firefighters, first responders, departments of health, educational facilities and community-based organizations can learn more about pre-ordering and purchasing NARCAN® Nasal Spray at (844) 4-NARCAN (844-462-7226) or customerservice@adaptpharma.com
 
In the United States, Adapt Pharma is located in Radnor, PA. Its global headquarters are in Dublin, Ireland.

Section iconCompany Overview

Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Adapt Pharma's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Adapt Pharma's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.